Ice cream products distributed in retail stores in nine American states have been recalled due to potential Listeria contamination, according to the United States Food and Drug Administration.
The states involved were New York, Massachusetts, Connecticut, Rhode Island, Vermont, Louisiana, Florida, Texas, and New Hampshire.
The recall was initiated by Royal Ice Cream after FDA sampling revealed Listeria monocytogenes' presence on processing equipment. It has expanded its recall to include all products manufactured at the facility within expiry.
Listeria monocytogenes is an organism that can cause serious and sometimes fatal infections in the young, frail or the elderly, and others with weakened immune systems.
Although healthy individuals may only experience short-term symptoms such as high fever, severe headache, stiffness, nausea, abdominal pain, and diarrhea. Listeria infection can also cause miscarriages and stillbirths among pregnant women.
Officials say all affected products will have the manufacturing plant number “CT121” or “CT#121”.
The affected brands were Royal Ice Cream, Batch brand, Ronny Brook Ice cream, New Orleans Ice cream, Maple Valley Ice Cream, Art Cream, Sweet Scoops Yogurt, Gelato Fiasco, Biggy Iggy’s Ice Cream Sandwiches, Munson Chip Wich Ice Cream sandwiches, Giffords Ice cream Sandwiches, Chewy Louie Ice Cream Sandwiches, Snow Wich Ice Cream Sandwich, and Newport Creamery.
So far, no illnesses have been reported related to the product. Those who have purchased the affected products are urged to return them to the place of purchase for a full refund.


U.S. Stocks Tumble as Iran Peace Deal Uncertainty Spooks Markets
Valero Port Arthur Refinery Explosion Prompts $1M Lawsuit Over Worker Safety Negligence
Global Flight Cancellations 2026: Middle East Air Travel Chaos Explained
WTO Reform Talks Begin in Cameroon Amid Global Trade Tensions
Moderna Stock Drops After FDA Declines Review of mRNA Flu Vaccine
Lynas Rare Earths Signs Vietnam Deal with LS Eco Energy to Boost Magnet Metal Production
RFK Jr. Overhauls Federal Autism Panel, Sparking Medical Community Backlash
Asian Currencies Hold Steady as Dollar Stays Firm Amid Middle East Uncertainty
Oil Prices Slip as Middle East Tensions Ease, Heading for Weekly Loss
SK Hynix Eyes Up to $14 Billion U.S. IPO to Fund AI Chip Expansion
Oil Prices Climb as Iran Reviews U.S. Peace Proposal Amid Middle East Tensions
Novocure Stock Surges 30% After FDA Approves Optune Pax for Pancreatic Cancer Treatment
Gold Prices Climb as Middle East Ceasefire Talks Stir Market Optimism
NAB Plans to Cut 170 Jobs While Expanding Offshore Operations
Novartis’ Vanrafia Shows Strong Phase 3 Results in IgA Nephropathy, Paving Way for Full Approval 



